IN8bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	21.94	27.09	11.12	21.28	18.18	37.02
Cash & Short-Term Investments	21.94	27.09	11.12	21.28	18.18	37.02
Cash Growth	84.56%	143.63%	-47.75%	17.05%	-50.89%	105.74%
Other Current Assets	0.72	0.79	1.46	3.34	4.05	1.96
Total Current Assets	22.66	27.88	12.58	24.63	22.23	38.98
Net Property, Plant & Equipment	3.25	4.04	7.83	8.57	10.3	2.83
Other Long-Term Assets	0.35	0.37	0.54	0.51	0.51	0.41
Total Assets	26.27	32.28	20.94	33.71	33.04	42.22
Accounts Payable	0.45	0.31	0.39	0.92	2.09	0.4
Accrued Expenses	0.68	1.63	1.05	2.96	2.34	1.24
Current Portion of Leases	1.03	1.22	1.65	1.51	1.39	0.63
Total Current Liabilities	2.16	3.16	3.08	5.39	5.82	2.26
Long-Term Leases	1.33	1.56	3.38	3.38	4.49	1.78
Total Long-Term Liabilities	1.33	1.56	3.38	3.38	4.49	1.78
Total Liabilities	3.48	4.72	6.47	8.77	10.31	4.04
Common Stock	0.01	-	-	0	0	0
Additional Paid-in Capital	168.96	168.64	136.13	116.15	83.94	70.87
Retained Earnings	-146.19	-141.1	-121.66	-91.22	-61.21	-32.69
Total Common Shareholders' Equity	22.78	27.56	14.48	24.94	22.73	38.18
Shareholders' Equity	22.78	27.56	14.48	24.94	22.73	38.18
Total Liabilities & Equity	26.27	32.28	20.94	33.71	33.04	42.22
Total Debt	2.35	2.78	5.03	4.89	5.87	2.41
Net Cash (Debt)	19.59	24.31	6.09	16.39	12.31	34.61
Net Cash Growth	-19.43%	299.18%	-62.84%	33.16%	-64.44%	94.23%
Net Cash Per Share	2.22	5.56	3.41	16.46	17.61	104.15
Book Value	22.78	27.56	14.48	24.94	22.73	38.18
Book Value Per Share	2.59	6.30	8.11	25.05	32.52	114.90
Tangible Book Value	22.78	27.56	14.48	24.94	22.73	38.18
Tangible Book Value Per Share	2.59	6.30	8.11	25.05	32.52	114.90

SEC Filings: 10-K · 10-Q